Massimo Nabissi Selected Research

Massimo Nabissi Research Topics

Disease

34	Neoplasms (Cancer) 04/2022 - 08/2009
12	Glioma (Gliomas) 01/2022 - 05/2010
11	Glioblastoma (Glioblastoma Multiforme) 10/2021 - 06/2012
7	Urinary Bladder Neoplasms (Bladder Cancer) 06/2022 - 09/2008
5	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2014
4	Adenocarcinoma 04/2022 - 01/2019
4	Necrosis 10/2021 - 01/2014
3	Circulating Neoplastic Cells 06/2022 - 01/2019
3	Breast Neoplasms (Breast Cancer) 11/2020 - 04/2019
3	Carcinogenesis 01/2020 - 01/2012
3	Multiple Myeloma 08/2017 - 06/2014
2	Carcinoma (Carcinomatosis) 01/2021 - 01/2012
2	Inflammation (Inflammations) 09/2020 - 01/2014
2	Hypoxia (Hypoxemia) 09/2020 - 04/2014
2	Endometrial Neoplasms (Endometrial Cancer) 07/2020 - 01/2020
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 03/2013
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2015 - 04/2014
1	Kidney Neoplasms (Kidney Cancer) 05/2022
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2022
1	Non-Muscle Invasive Bladder Neoplasms 11/2021
1	Brain Neoplasms (Brain Tumor) 10/2021
1	Lymphoma (Lymphomas) 01/2021
1	Reinfection 12/2020
1	Chronic Pain 09/2020
1	Infections 09/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Uterine Neoplasms (Uterine Cancer) 01/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 09/2018

Drug/Important Bio-Agent (IBA)

10	Messenger RNA (mRNA)IBA 06/2022 - 09/2008
8	CannabidiolIBA 04/2022 - 01/2013
7	LigandsIBA 07/2020 - 10/2012
7	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2010
6	Pharmaceutical PreparationsIBA 04/2022 - 01/2013
6	CationsIBA 01/2020 - 10/2012
5	Ion Channels (Ion Channel)IBA 04/2022 - 12/2014
5	CannabinoidsIBA 01/2021 - 10/2012
4	Capsaicin (Zostrix)FDA Link 05/2022 - 08/2009
4	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2012
3	Biological ProductsIBA 01/2021 - 04/2019
3	Temozolomide (Temodar)FDA LinkGeneric 01/2021 - 01/2019
3	CalciumIBA 01/2020 - 12/2014
3	Bortezomib (Velcade)FDA Link 01/2017 - 06/2014
3	Tyrosine Kinase InhibitorsIBA 01/2017 - 01/2015
2	VimentinIBA 01/2022 - 11/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2017
2	Dronabinol (THC)FDA LinkGeneric 01/2021 - 11/2016
2	Everolimus FDA Link 11/2020 - 04/2014
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 09/2020 - 01/2018
2	AntibodiesIBA 01/2020 - 01/2019
2	RutheniumIBA 01/2020 - 06/2014
2	Transient Receptor Potential ChannelsIBA 01/2020 - 01/2020
2	ParaffinIBA 03/2018 - 09/2008
2	Axitinib (AG 013736)IBA 01/2017 - 11/2015
2	Proteasome InhibitorsIBA 01/2017 - 11/2016
2	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2015 - 02/2015
2	LysophospholipidsIBA 02/2014 - 01/2014
1	evening primrose oilIBA 04/2022
1	Imatinib Mesylate (Gleevec)FDA Link 04/2022
1	Immune Checkpoint ProteinsIBA 11/2021
1	Protein Isoforms (Isoforms)IBA 10/2021
1	Core Binding Factor Alpha 2 SubunitIBA 10/2021
1	Annexin A5IBA 10/2021
1	Calcium Gluconate (CBG)IBA 01/2021
1	cannabigerolIBA 01/2021
1	GlucansIBA 12/2020
1	ribociclibIBA 11/2020
1	OzoneIBA 09/2020
1	Oxygen (Dioxygen)IBA 09/2020
1	HydrazonesIBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	Free RadicalsIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	Estrogens (Estrogen)FDA Link 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	tranilastIBA 01/2020
1	Microphthalmia-Associated Transcription FactorIBA 01/2020
1	mesoxalonitrileIBA 04/2019
1	bafilomycin AIBA 04/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2019
1	Carbonyl Cyanide m-Chlorophenyl Hydrazone (CCCP)IBA 04/2019
1	SphingomyelinsIBA 04/2019
1	N-Methylaspartate (NMDA)IBA 04/2019
1	Antineoplastic Agents (Antineoplastics)IBA 04/2019
1	1,4-dioxane (dioxane)IBA 04/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2019
1	isofuranodieneIBA 01/2019
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 09/2018
1	Salmeterol Xinafoate (Serevent)FDA Link 09/2018
1	YM 976IBA 09/2018
1	Interleukin-8 (Interleukin 8)IBA 09/2018
1	thyme extractIBA 09/2018

Therapy/Procedure

12	Therapeutics 10/2021 - 06/2012
6	Drug Therapy (Chemotherapy) 04/2022 - 01/2013
4	Castration 01/2020 - 01/2014
3	Immunotherapy 11/2021 - 01/2018
1	Precision Medicine 01/2021
1	Adjuvant Chemotherapy 09/2020